Research Article

Copper- and Ligand-Free Sonogashira Cross-Coupling: Access to Novel 3-Aminoindole Derivatives and Their Biological Evaluations

Table 4

ADMET predictions of 3-aminoindole derivatives 10a–t.

StructureMW (g/mol)Predicted ADMET propertiesRules satisfied
LogSLogPPlasma protein binding (PPB) (%)nHAnHDH-HThERG blockerTPSALipinskiPfizerGSK

10a443.98−7.797.08101.7220.190.1827.82YesNoNo
10b390.07−6.725.8699.83220.250.2527.82YesNoNo
10c370.07−6.394.9897.63310.280.06928.26YesNoNo
10d352.05−7.206.43100.6220.210.5627.82YesNoNo
10e382.13−6.305.88100.7320.970.8937.05YesNoNo
10f298.15−5.534.8899.57220.380.4327.82YesNoNo
10g314.14−6.615.3499.38320.410.5337.05YesNoNo
10h262.15−5.854.9397.36210.240.4319.03YesNoNo
10i316.14−5.664.98100.1220.580.7027.82YesNoNo
10j332.13−6.725.4599.73320.590.7437.05YesNoNo
10k402.07−7.386.76101.3320.970.8637.05YesNoNo
10l386.01−7.526.86101.6220.160.7027.82YesNoNo
10m416.09−6.716.40101.5320.960.9137.05YesNoNo
10n332.11−6.165.54100.1220.220.7027.82YesNoNo
10o348.10−7.105.9599.97320.300.7637.05YesNoNo
10p393.11−7.196.08100.8420.990.9260.84YesNoNo
10q407.12−6.505.66101.1420.990.9460.84YesNoNo
10r323.14−5.834.52100.2320.880.8251.61YesNoNo
10s339.14−6.895.0599.86420.880.8760.84YesNoNo
10t287.14−6.384.6197.75120.860.8742.82YesNoNo

MW-molecular weight: 100–600 g/mol, LogS (predicted aqueous solubility): −4–0.5 log mol/L, LogP (predicted octanol/water partition coefficient): 0–3, human hepatotoxicity (H H-T): 0 (nontoxic)–+1 (toxic), hERG blockers: 0 (inactive)–+1 (active), protein plasma binding (PPB): <90%, number of hydrogen acceptors (nHA): 0–12, number of hydrogen donors (nHD): 0–7, GSK’s rule: MW ≤ 400, LogP ≤4, Pfizer’s rule: LogP ≤3, topological polar surface area (TPSA) >75, Lipinski’s rule: MW ≤500, LogP ≤5, number of hydrogen acceptors (nHA) ≤10, number of hydrogen donors (nHD) ≤5.